Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
08.12.23
/
50%
€37.60
Target price
08.12.24
€66.97
Performance (%)
2.13%
Price
08:19
€38.20
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 2.13%. This prediction currently runs until 08.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 1.053% | 1.053% |
| iShares Core DAX® | 0.051% | 5.593% |
| iShares Nasdaq 100 | 1.808% | 7.445% |
| iShares Nikkei 225® | 2.181% | 2.815% |
| iShares S&P 500 | 1.040% | 4.975% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $72.00 price target on the stock.
Ratings data for RARE provided by MarketBeat